NYC Flu Shot 2020, Flu Shot At Home

NYC Flu Shot 2020
By Leaa Health NYC

By NYC Licensed Physicians. 
2020 Flu Shot At Home
Only $75 for none members
Plus $150 for the doctor visit

book Here























Are You Immune To COVID-19?

PCR COVID-19 Test For travel 
get tested at home 
FDA Approved Antibody Test By Blood Draw.
Prices does not include the visit

LEARN MORE

Flu Shot at home

Changes to the 2019-2020 Northern Hemisphere vaccines from 2018-2019 U.S. flu vaccines?
Flu vaccines are updated to match circulating viruses better.

The A(H1N1)pdm09 vaccine component was updated from an A/Michigan/45/2015 (H1N1)pdm09-like virus to an A/Brisbane/02/2018 (H1N1)pdm09-like virus. The A(H3N2) vaccine component was updated from an A/Singapore/INFIMH-16-0019/2016 A(H3N2)-like virus to an A/Kansas/14/2017 (H3N2)-like virus. Both B/Victoria and B/Yamagata virus components from the 2018-2019 flu vaccine remain the same for the 2019-2020 flu vaccine.
What viruses will the 2019-2020 flu vaccines protect against?
There are many different flu viruses, and they are continually changing. The composition of U.S. flu vaccines is reviewed annually and updated as needed to match circulating flu viruses. Flu vaccines protect against the three or four viruses (depending on the vaccine) that research suggests will be most common. For 2019-2020, trivalent (three-component) vaccines are recommended to contain:

A/Brisbane/02/2018 (H1N1)pdm09-like virus (updated)
A/Kansas/14/2017 (H3N2)-like virus (updated)
B/Colorado/06/2017-like (Victoria lineage) virus
Quadrivalent (four-component) vaccines, which protect against a second lineage of B viruses, are recommended to contain:

the three recommended viruses above, plus B/Phuket/3073/2013-like (Yamagata lineage) virus.
The World Health Organization (WHO) made the selection of the H1N1 and both B components for 2019-2020 Northern Hemisphere flu vaccines on February 21 and at that time decided to delay the decision on an H3N2 vaccine component. FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) also selected the H1N1 and B components at their first meeting on March 6 but also decided to postpone the selection of the H3N2 component. WHO selected the H3N2 component listed above on March 21, 2019. VRBPAC chose the same H3N2 component for U.S. vaccines on March 22, 2019.

contact

P#:866 275 7594
Email: support@Leaa.io
Sun - Fri
7:00am -11:00pm

HQ

510 FIFTH AVE NYC
& 195 BROADWAY
THIRD FLOOR


IV Drip

NAD IV 
Hangover IV
Skin Whitening IV 
IV Therapy  
Vitamin C IV
R Blend
M Blend


Terms

Terms
Policy
Hipaa
Accessibility



Medical Providers On Demand Home Visits LEAA LLC EST 2017© Copyright
The Content On This Website Is Copyright Protected All Rights Reserved.